. Author manuscript; available in PMC: 2018 Feb 1.

Published in final edited form as: J Pediatr. 2016 Nov 7;181:298–301.e1. doi: 10.1016/j.jpeds.2016.10.039

Table II.

Variables associated with medications continuation at the time of discharge to home among the 317 survivors of acute symptomatic seizures

			Univariable analyses^*			Multivariable analyses^†

	n	Discharged with AED	RR	95% CI	P	OR	95% CI	P
EEG confirmed seizures
Yes	266	206 (77%)	1.5	(1.2–2.0)	.0001	2.3	(0.97–5.4)	.06
No	51	26 (51%)
Status epilepticus
Yes	48	42 (88%)	1.2	(1.1–1.4)	.015	2.1	(0.6–7.3)	.2
No	269	190 (71%)
Seizures refractory to initial loading dose
Yes	196	160 (82%)	1.3	(1.1–1.5)	.0003	1.6	(0.8–3.2)	.2
No/unknown	115	71 (62%)
Abnormal examination at discharge
Yes	150	123 (82%)	1.3	(1.1–1.4)	.0008	2.0	(0.99–4.1)	.053
No	167	109 (67%)

AED, antiepileptic drug; RR, relative risk.

χ².

^†

Wald P value adjusted for each of the risk factors plus site, and etiology, which remain highly significant (P < .0005).